196 related articles for article (PubMed ID: 38394476)
1. Racial/Ethnic Disparities in Pathologic Complete Response and Overall Survival in Patients With Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy.
Woriax HE; Thomas SM; Plichta JK; Rosenberger LH; Botty van den Bruele A; Chiba A; Hwang ES; DiNome ML
J Clin Oncol; 2024 May; 42(14):1635-1645. PubMed ID: 38394476
[TBL] [Abstract][Full Text] [Related]
2. Racial Differences in the Use and Outcome of Neoadjuvant Chemotherapy for Breast Cancer: Results From the National Cancer Data Base.
Killelea BK; Yang VQ; Wang SY; Hayse B; Mougalian S; Horowitz NR; Chagpar AB; Pusztai L; Lannin DR
J Clin Oncol; 2015 Dec; 33(36):4267-76. PubMed ID: 26598753
[TBL] [Abstract][Full Text] [Related]
3. State Variation in Racial and Ethnic Disparities in Incidence of Triple-Negative Breast Cancer Among US Women.
Sung H; Wiese D; Jatoi I; Jemal A
JAMA Oncol; 2023 May; 9(5):700-704. PubMed ID: 36862439
[TBL] [Abstract][Full Text] [Related]
4. Correlates of Triple Negative Breast Cancer and Chemotherapy Patterns in Black and White Women With Breast Cancer.
Sheppard VB; Cavalli LR; Dash C; Kanaan YM; Dilawari AA; Horton S; Makambi KH
Clin Breast Cancer; 2017 Jun; 17(3):232-238. PubMed ID: 28189497
[TBL] [Abstract][Full Text] [Related]
5. Response to Treatment, Racial and Ethnic Disparity, and Survival in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy in the US.
Shubeck S; Zhao F; Howard FM; Olopade OI; Huo D
JAMA Netw Open; 2023 Mar; 6(3):e235834. PubMed ID: 36995711
[TBL] [Abstract][Full Text] [Related]
6. Lack of racial differences in clinical outcomes of breast cancer patients receiving neoadjuvant chemotherapy: a single academic center study.
Sarma M; Perimbeti S; Nasir S; Attwood K; Kapoor A; O'Connor T; Early A; Levine EG; Takabe K; Kalinski P; Ambrosone C; Khoury T; Yao S; Gandhi S
Breast Cancer Res Treat; 2022 Apr; 192(2):411-421. PubMed ID: 35000093
[TBL] [Abstract][Full Text] [Related]
7. Racial disparities in treatment and outcomes between non-Hispanic Black and non-Hispanic White women with nonmetastatic inflammatory breast cancer.
Carbajal-Ochoa WH; Johnson D; Alvarez A; Bernal AM; Anampa JD
Breast Cancer Res Treat; 2023 Sep; 201(2):275-287. PubMed ID: 37442877
[TBL] [Abstract][Full Text] [Related]
8. Gender, Racial and Ethnic Differences in Pathologic Response Following Neoadjuvant Chemotherapy for Bladder Cancer Patients.
Paster IC; Zeng J; Recio-Boiles A; Chipollini J
Urology; 2023 Aug; 178():105-113. PubMed ID: 37230271
[TBL] [Abstract][Full Text] [Related]
9. Racial and Socioeconomic Treatment Disparities in Adolescents and Young Adults with Stage II-III Rectal Cancer.
Lee DY; Teng A; Pedersen RC; Tavangari FR; Attaluri V; McLemore EC; Stern SL; Bilchik AJ; Goldfarb MR
Ann Surg Oncol; 2017 Feb; 24(2):311-318. PubMed ID: 27766558
[TBL] [Abstract][Full Text] [Related]
10. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States.
Iqbal J; Ginsburg O; Rochon PA; Sun P; Narod SA
JAMA; 2015 Jan; 313(2):165-73. PubMed ID: 25585328
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Neoadjuvant
Philipovskiy A; Corral J; Dwivedi KA; Heydarian R; Gaur S
In Vivo; 2019; 33(4):1227-1234. PubMed ID: 31280213
[TBL] [Abstract][Full Text] [Related]
12. Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel.
Sharma P; López-Tarruella S; García-Saenz JA; Khan QJ; Gómez HL; Prat A; Moreno F; Jerez-Gilarranz Y; Barnadas A; Picornell AC; Monte-Millán MD; González-Rivera M; Massarrah T; Pelaez-Lorenzo B; Palomero MI; González Del Val R; Cortés J; Fuentes-Rivera H; Morales DB; Márquez-Rodas I; Perou CM; Lehn C; Wang YY; Klemp JR; Mammen JV; Wagner JL; Amin AL; O'Dea AP; Heldstab J; Jensen RA; Kimler BF; Godwin AK; Martín M
Clin Cancer Res; 2018 Dec; 24(23):5820-5829. PubMed ID: 30061361
[TBL] [Abstract][Full Text] [Related]
13. Differences in Stage of Cancer at Diagnosis, Treatment, and Survival by Race and Ethnicity Among Leading Cancer Types.
Zhang C; Zhang C; Wang Q; Li Z; Lin J; Wang H
JAMA Netw Open; 2020 Apr; 3(4):e202950. PubMed ID: 32267515
[TBL] [Abstract][Full Text] [Related]
14. Racial/ethnicity disparities in invasive breast cancer among younger and older women: An analysis using multiple measures of population health.
Hung MC; Ekwueme DU; Rim SH; White A
Cancer Epidemiol; 2016 Dec; 45():112-118. PubMed ID: 27792934
[TBL] [Abstract][Full Text] [Related]
15. Racial and ethnic disparities in lung transplant listing and waitlist outcomes.
Mooney JJ; Hedlin H; Mohabir P; Bhattacharya J; Dhillon GS
J Heart Lung Transplant; 2018 Mar; 37(3):394-400. PubMed ID: 29129372
[TBL] [Abstract][Full Text] [Related]
16. Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors.
Warner ET; Tamimi RM; Hughes ME; Ottesen RA; Wong YN; Edge SB; Theriault RL; Blayney DW; Niland JC; Winer EP; Weeks JC; Partridge AH
J Clin Oncol; 2015 Jul; 33(20):2254-61. PubMed ID: 25964252
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes with neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer: A report from the National Cancer Database.
Bagegni NA; Tao Y; Ademuyiwa FO
PLoS One; 2019; 14(9):e0222358. PubMed ID: 31536530
[TBL] [Abstract][Full Text] [Related]
18. Racial/Ethnic Disparities in All-Cause Mortality among Patients Diagnosed with Triple-Negative Breast Cancer.
Wang F; Zheng W; Bailey CE; Mayer IA; Pietenpol JA; Shu XO
Cancer Res; 2021 Feb; 81(4):1163-1170. PubMed ID: 33272926
[TBL] [Abstract][Full Text] [Related]
19. Racial/Ethnic Disparities in the Performance of Prediction Models for Death by Suicide After Mental Health Visits.
Coley RY; Johnson E; Simon GE; Cruz M; Shortreed SM
JAMA Psychiatry; 2021 Jul; 78(7):726-734. PubMed ID: 33909019
[TBL] [Abstract][Full Text] [Related]
20. Update on triple-negative breast cancer disparities for the United States: A population-based study from the United States Cancer Statistics database, 2010 through 2014.
Scott LC; Mobley LR; Kuo TM; Il'yasova D
Cancer; 2019 Oct; 125(19):3412-3417. PubMed ID: 31282032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
